Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07766889
What this trial is testing

Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell CarcinomaHead and Neck CancerLocally Advanced Head and Neck Cancer+1 more
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07379424
What this trial is testing

A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
chen chao Professor 37
Large-scale testing (Phase 3)UnknownNCT03958890
What this trial is testing

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Henlius Biotech 489
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Large-scale testing (Phase 3)Study completedNCT00416858
What this trial is testing

Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 40
Very early researchNot Yet RecruitingNCT07168785
What this trial is testing

[18F]-AraG PET Imaging in LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Locally Advanced Head and Neck Squamous Cell Carcinoma
Indiana University 5
Testing effectiveness (Phase 2)Ended earlyNCT03278626
What this trial is testing

Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
NYU Langone Health 12
Early research (Phase 1)Ended earlyNCT00906360
What this trial is testing

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+29 more
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT07068568
What this trial is testing

Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma

Who this might be right for
Basal Cell CancerEyelid TumorBasal Cell Carcinoma (BCC)+1 more
Federico II University 12
Testing effectiveness (Phase 2)Looking for participantsNCT07665190
What this trial is testing

Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Hypopharyngeal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07554768
What this trial is testing

Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell Carcinoma
Chen Chunyan 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT06914011
What this trial is testing

Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Asan Medical Center 172
Testing effectiveness (Phase 2)Study completedNCT01185171
What this trial is testing

Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Chicago 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06895369
What this trial is testing

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Sir Run Run Shaw Hospital 30
Very early researchStudy completedNCT00140556
What this trial is testing

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerPharynx Cancer
David M. Brizel, MD 28
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Testing effectiveness (Phase 2)Active Not RecruitingNCT05366166
What this trial is testing

Pembrolizumab Plus Olaparib in LA-HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
UNC Lineberger Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT05156060
What this trial is testing

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerLocally Advanced Head and Neck Carcinoma
Natalie Lockney 64
Testing effectiveness (Phase 2)Study completedNCT00358930
What this trial is testing

ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60
Next Page